# Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)

> **NCT06646744** · — · COMPLETED · sponsor: **Ana Belen Rivas Paterna** · enrollment: 2100 (actual)

## Conditions studied

- COVID-19 Vaccine Adverse Reaction

## Interventions

- **BIOLOGICAL:** mRNA COVID-19 vaccine

## Key facts

- **NCT ID:** NCT06646744
- **Lead sponsor:** Ana Belen Rivas Paterna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2023-03-03
- **Final completion:** 2023-03-03
- **Target enrollment:** 2100 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646744, "Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06646744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*